Overcoming Specialty Drug Treatment Challenges

Thomas Morrow, MD, chief medical officer at Next IT, discusses the various difficulties faced by patients when they begin a specialty therapy regimen.

Related Content:

InterviewsSpecialty Pharmacy

FDA Lifts Clinical Hold on Lenacapavir for HIV Treatment and PrEP

Expert: Cell, Gene Therapy Research Has Weathered the Storm of COVID-19, Leaving a Bright Future Ahead

Expert: Cell, Gene Therapies Provide the Important Opportunity to ‘Move Beyond Chronic Disease Management to Curative Areas’